| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exelixis, Inc. (EXEL) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. EXEL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.96M | $100.87M | - | |
| Dir | 1.55M | $79.74M | - | |
| Dir | 1.19M | $61.05M | - | |
| CFO | 1.12M | $57.36M | - | |
| VP | 594.7K | $30.53M | -43,451 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 23, 2020 | Schwab Gisela67 | Pres, Prod Dev &Med Aff &CMO | Sale+OE | 100,000 | $26.00 | $2,600,000.00 | -23.5% | |
| Apr 22, 2020 | Scangos George A77 | Director | Sell | 60,000 | $24.08 | $1,445,079.00 | -1.4% | |
| Apr 20, 2020 | Haley Patrick J.56 | EVP, Commercial | Sale+OE | 5,000 | $24.00 | $120,000.00 | -4.1% | |
| Apr 15, 2020 | Scangos George A77 | Director | Sell | 25,000 | $18.31 | $457,750.00 | -2.7% | |
| Apr 8, 2020 | Scangos George A77 | Director | Sell | 23,500 | $18.28 | $429,581.50 | -1.2% | |
| Apr 6, 2020 | Lamb Peter63 | EVP, Scientific Strategy &CSO | Sale+OE | 50,000 | $17.26 | $863,000.00 | -28.3% | |
| Apr 3, 2020 | Wyszomierski Jack L | Director | Sale+OE | 13,848 | $16.57 | $229,461.36 | -7.9% | |
| Mar 31, 2020 | Scangos George A77 | Director | Sell | 1,500 | $18.06 | $27,090.00 | -0.2% | |
| Mar 20, 2020 | Haley Patrick J.56 | EVP, Commercial | Sell | 4,318 | $15.37 | $66,367.66 | -3.6% | |
| Mar 4, 2020 | Schwab Gisela67 | Pres, Prod Dev &Med Aff &CMO | Sale+OE | 100,000 | $19.40 | $1,940,000.00 | -12.5% |